000			03662nam a2200277 i 4500
008			820623s2006 nyua o 000 0 eng d
020			_a9780120103423
040			_aBAUN _beng _cBAUN
049			_aBAUN_MERKEZ
050	0	4	_aQY90 _b.M35 2006
245	0	0	_aAdvances in clinical chemistry / _cedited by Gregory S. Makowski.
264		1	_aNew York : _bAcademic Press, _c2006.
300			_axi, 336 pages : _billustrations, diagrams ; _c23 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
490	0		_aAdvances in clinical chemistry ; _v42
505	0	0	_tContents _t-- Contributors _t-- Preface _t-- Chapter 1: Tumor Markers in Detection of Lung Cancer _t-- 1. Abstract _t-- 2. Introduction _t-- 3. Blood/Serum Tumor Markers in the Detection of Lung Cancers _t-- 4. Role of Serum Tumor Markers in the Detection of Lung Cancers _t-- 5. Role of Other Serum Markers in the Detection of Lung Cancers _t-- 6. Role of a Tumor Marker Panel in Improving the Detection of Lung Cancers _t-- 7. Value of Less Frequently Used Markers in the Diagnosis of Lung Cancers _t-- 8. Summary and Conclusions _t-- References _t-- Chapter 2: Advances in Serum Protein Electrophoresis _t-- 1. Abstract _t-- 2. Introduction _t-- 3. Technique _t-- 4. Instruments _t-- 5. Precision _t-- 6. Comparison with Gel-Based Techniques _t-- 7. Reference Intervals _t-- 8. Electrophoretic Patterns _t-- 9. Online Processing of Digital Absorbance Data _t-- 10. Detection of Monoclonal Proteins _t-- 11. Typing of Monoclonal Proteins _t-- 12. Urine and Body Fluid Analysis _t-- 13. Quality Control _t-- 14. Interferences _t-- 15. "Open" Capillary Electrophoresis Systems _t-- 16. Conclusions _t-- Acknowledgment _t-- References _t-- Chapter 3: Aspirin Resistance: A. Review Of Diagnostic. Methodology, Mechanisms, and Clinical Utility _t-- 1. Abstract _t-- 2. Introduction _t-- 3. Aspirin: Mechanism of Action _t-- 4. Methods to Detect Aspirin Resistance _t-- 5. Aspirin Resistance Associated with Adverse Outcomes _t-- 6. Mechanisms of Aspirin Resistance _t-- 7. Aspirin Resistance Associated with Cardiovascular and Cerebrovascular Disease _t-- 8. Summary and Recommendations _t-- References _t-- Chapter 4: Vitreous Fluid Biomarkers _t-- 1. Abstract _t-- 2. Introduction _t-- 3. Methods _t-- 4. Molecular Biology _t-- 5. Ocular Disease and Clinical Significance _t-- 6. Conclusions _t-- References _t-- Chapter 5: Tumor-associated Carbonic Anhydrases and Their Clinical Significance _t-- 1. Abstract _t-- 2. Carbonic Anhydrases _t-- 3. Basic Characteristics of CA IX and CA XII _t-- 4. Regulation of CA IX/CA XII Expression _t-- 5. Distribution of CA IX/CA XII in Tumors and Their Clinical Usefulness _t-- 6. Role of CA IX/CA XII in Tumor Progression _t-- 7. CA IX and CA XII as Molecular Targets for Anticancer Therapy _t-- 8. Concluding Remarks _t-- Acknowledgments _t-- References _t-- Chapter 6: Mitochondrial Disease: Maintenance of Mitochondrial Genome and Molecular Diagnostics _t-- 1. Abstract _t-- 2. Introduction _t-- 3. Human Mitochondrial DNA _t-- 4. Maintenance of Mitochondrial DNA _t-- 5. Pathogenesis of Mitochondrial DNA Mutation _t-- 6. Tests of Mitochondrial DNA _t-- 7. Mitochondrial DNA in Common Disease _t-- 8. Nuclear DNA Mutations and Mitochondrial Disease _t-- 9. Perspectives _t-- 10. Conclusion and Remarks _t-- Acknowledgments _t-- References _t-- Chapter 7: Microfluidic Enzyme-Linked Immunosorbent Assay Technology _t-- 1. Abstract _t-- 2. Introduction _t-- 3. Key Issues in Develo.
650		0	_aClinical chemistry.
650		0	_aBiochemistry.
700	1		_aMakowski, Gregory S.
710	2		_aebrary, Inc.
900			_a19533
900			_bSatın
942			_2lcc _cKT
999			_c16705 _d16705